From: Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Sample | Signal intensity | Tumor/normal | TNM staging | Age | Gender |
---|---|---|---|---|---|
Tumor/normal | 18370/60015 | 0.31 | II; T4N0M0 | 67 | Female |
Tumor/normal | 31402/35431 | 0.89 | I; T1N0M0 | 58 | Female |
Tumor/normal | 57125/96121 | 0.59 | IV; T4N0M0 | 43 | Female |
Tumor/normal | 20382/23650 | 0.86 | IIIB; T3N1M0 | 69 | Female |
Tumor/normal | 28165/59167 | 0.48 | IIIB; T3N1M0 | 35 | Female |
Tumor/normal | 22193/12912 | 1.72 | IIIA; T4N0M0 | 58 | Male |
Tumor/normal | 18569/28122 | 0.66 | IIIB; T4N1M0 | 63 | Male |
Tumor/normal | 9863/28914 | 0.34 | IIA; T2N0M0 | 73 | Female |
Tumor/normal | 21780/34774 | 0.63 | IIIB; T4N0M? | 65 | Female |
Tumor/normal | 22429/45939 | 0.49 | IIIA; T3N1M0 | 65 | Female |